Grantham, Mayo, Van Otterloo & Co (GMO)’s Brookdale Senior Living BKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-112,400
Closed -$510K – 721
2022
Q2
$510K Buy
112,400
+7,400
+7% +$43.7K ﹤0.01% 610
2022
Q1
$740K Buy
105,000
+93,100
+782% +$568K ﹤0.01% 559
2021
Q4
$61K Sell
11,900
-170,400
-93% -$1.06M ﹤0.01% 675
2021
Q3
$1.15M Buy
+182,300
New +$1.3M 0.01% 516
2021
Q1
– Sell
-37,500
Closed -$166K – 846
2020
Q4
$166K Buy
+37,500
New +$138K ﹤0.01% 785

Other funds holding BKD

Grantham, Mayo, Van Otterloo & Co (GMO)'s BKD Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Brookdale Senior Living (BKD) in Q3 2022, closing a stake of 112,400 shares — an estimated $510K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BKD in Q4 2020 and held it in 5 quarters. The position peaked at $1.15M in Q3 2021. 168 funds tracked by Wall St. Rank hold BKD as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Brookdale Senior Living position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 112,400 Brookdale Senior Living shares in Q3 2022, an estimated $510K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Brookdale Senior Living in Q4 2020 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Brookdale Senior Living position peaked at $1.15M in Q3 2021.
  • 168 funds tracked by Wall St. Rank held Brookdale Senior Living as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.